Integre Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-9,948
Closed -$1.45M 213
2017
Q3
$1.45M Sell
9,948
-1,371
-12% -$187K 0.97% 45
2017
Q2
$1.47M Buy
11,319
+62
+0.6% +$7.6K 0.89% 42
2017
Q1
$1.4M Hold
11,257
0.82% 42
2016
Q4
$1.3M Buy
11,257
+1,776
+19% +$198K 0.42% 59
2016
Q3
$991K Hold
9,481
0.31% 65
2016
Q2
$935K Hold
9,481
0.33% 61
2016
Q1
$949K Buy
9,481
+3,560
+60% +$367K 0.28% 63
2015
Q4
$709K Hold
5,921
0.17% 103
2015
Q3
$640K Buy
+5,921
New +$735K 0.15% 110

Other funds holding CELG

Integre Asset Management's CELG Position: Q4 2017 in Review

Integre Asset Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 9,948 shares — an estimated $1.45M sold.

Integre Asset Management first reported a position in CELG in Q3 2015 and held it in 9 quarters. The position peaked at $1.47M in Q2 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Integre Asset Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Integre Asset Management sold 9,948 Celgene Corp shares in Q4 2017, an estimated $1.45M.
  • Integre Asset Management first reported a position in Celgene Corp in Q3 2015 and held it in 9 quarters.
  • Integre Asset Management's Celgene Corp position peaked at $1.47M in Q2 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Integre Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.